Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

At around 11 a.m. last December 30, from his office in Oklahoma City, an inventor named David Albert uploaded a webcam video in which he demonstrated how to obtain an electrocardiogram with an iPhone.

Opening his shirt and white lab coat, he placed the phone against his chest. “Now you will see a very clean ECG,” Albert explained, as a heart rhythm pulsed across the screen. “I am detecting and storing, wirelessly transmitting, and storing locally in real time. It’s being analyzed, beats are being identified.”

By noon, the video had 10,000 views. Three days later, it had 100,000. Bloggers and online commenters were insisting the iPhone ECG was a fraud. That was enough to impress Albert’s 12-year-old son: “Dad, you’ve made it. You have YouTube haters!”

The story of the iPhone ECG may also be remembered as an early demonstration of how mobile technology made medicine faster and cheaper. U.S. industry delivers constant advances in high-tech medicine, including new drugs and million-dollar medical scanners. But it does so at a staggering cost. After posting the video, Albert, who is 56, was flooded with thousands of inquiries from first responders and doctors all over the world, as well as from executives at big medical-device firms. “It’s very clear the established companies view this as a threat,” he says.

A serial inventor with 33 issued patents, Albert says that for much of his career, including his years as a top cardiology scientist for General Electric, he was part of the problem. “The job was to create 10 percent improvements in performance for 100 percent price increases,” he says. “For 25 years, I designed ever more expensive technology.”

The ECG reader being developed by Albert’s company, AliveCor, will cost around $100. While it’s not as accurate as a hospital-grade 12-lead ECG, the kind that uses many electrodes pasted to the chest, arms, and legs, Albert calls his phone ECG “almost as good and disruptively less expensive.”

ECGs are used to diagnose irregular heartbeats, or arrhythmias, a common type of medical problem that can also be the result of a heart attack. AliveCor’s monitor is built into a case that slips onto an iPhone. It has two electrodes that pick up voltage changes on the skin—the ECG signal—produced by the contraction of the heart. A low-power wireless transmitter sends the signal to the phone. Power comes from a lithium watch battery that Albert claims will last for 180 hours of continuous use.

1 comment. Share your thoughts »

Credit: AliveCor
Video by AliveCor

Tagged: Business, Business Impact, The Era of E-Medicine, AliveCor

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me